Analysis of Urinary Retention Caused by Selective β 3-adrenoceptor Agonists Using the Japanese Adverse Drug Event Report Database (JADER)
Die Pharmazie · 01.05.2023 · 78 (5)
DOI: 10.31083/ph.2023.3509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Die Pharmazie, online erschienen am 01.05.2023. Verfasst von T. Kawazoe und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Overactive bladder (OAB) is a frequent chronic disorder which impairs quality of life by frequent, uncontrollable urination. Newly developed selectiveβ 3-adrenoceptor agonists (sβ 3-agonists) have the same efficacy in treating OAB but significantly fewer side effects than the traditionally used anti-muscarinics. However, safety data on these compounds are scarce. In this study, we analysed the occurrence of adverse effects in patients taking sβ 3-agonists and their characteristics using the JADER database. The most frequently reported adverse effect associated with the use of sβ 3-agonists was urinary retention [mirabegron; crude reporting odds ratios (ROR): 62.1, 95% confidence interval (CI): 52.0–73.6, P
Zitieren
APA
Kawazoe, T., Ishida, T., Jobu, K., Kawada, K., Yoshioka, S., & Miyamura, M. (2023). Analysis of Urinary Retention Caused by Selective β 3-adrenoceptor Agonists Using the Japanese Adverse Drug Event Report Database (JADER). Die Pharmazie, 78(5). https://doi.org/10.31083/ph.2023.3509
Vancouver
Kawazoe T, Ishida T, Jobu K, Kawada K, Yoshioka S, Miyamura M. Analysis of Urinary Retention Caused by Selective β 3-adrenoceptor Agonists Using the Japanese Adverse Drug Event Report Database (JADER). Die Pharmazie. 2023;78(5). doi:10.31083/ph.2023.3509
BibTeX
@article{Kawazoe2023,
author = {Kawazoe, T. and Ishida, T. and Jobu, K. and Kawada, K. and Yoshioka, S. and Miyamura, M.},
title = {Analysis of Urinary Retention Caused by Selective β 3-adrenoceptor Agonists Using the Japanese Adverse Drug Event Report Database (JADER)},
journal = {Die Pharmazie},
year = {2023},
volume = {78},
number = {5},
doi = {10.31083/ph.2023.3509}
}
EUVIMED